Rêve Solutions helps pharmaceutical and biotech sponsors make structured, defensible decisions on clinical trial expansion into African corridors — before operational commitments are made.
Interim and fractional IMP supply management for sponsors running Phase I–III programmes with European trial sites.
Looking for fractional or interim supply capacity in Europe? →Structured Go / Conditional Go / No-Go assessments for sponsors evaluating clinical trial expansion into African corridors, built on the CCIM™ framework. Delivered as a decision pack for sponsor leadership.
Explore the CCIM™ Framework →Senior IMP supply management on a fractional or interim basis — a named lead at 0.4 to 1.0 FTE, under a vendor contract rather than a headcount. For sponsors who need the function but cannot justify, or cannot fill, a permanent hire.
Explore capacity →“Africa is not an execution problem waiting to be solved. It is a decision problem waiting to be structured.” — The Rêve Solutions Principle
Africa represents 19% of the world's population and over 25% of the global disease burden, with treatment-naive patient pools and indication-aligned disease profiles.
Yet most sponsors hesitate. Not because the science is unclear — but because three operational uncertainties remain unaddressed before any commitment is made.
Country-Contextualised IMP Management. A proprietary, five-layer decision tool that assesses readiness — from program sensitivity to strategic ROI — and produces a Go/No-Go Decision Pack before any operational commitment is made.
The Rwanda and Kenya corridors have both been assessed end to end under CCIM™, each scoring 80/100 under balanced weighting. The framework's knowledge base covers more than twelve African markets.
Structured Go / Conditional Go / No-Go assessments for sponsor leadership, built on CCIM™. The evidence base for a defensible expansion commitment.
Independent assessment of specific African corridors — customs, depots, last-mile, governance — based on direct primary-source audits, not desk research.
ICH E6(R3)-aligned oversight structures, MTTD frameworks, and escalation protocols for sponsors operating in emerging-market corridors.
Senior clinical supply management on a fractional or interim basis for sponsors running Phase I–III programmes in Europe. The function, without the headcount.
Explore capacity →
Révérien Uwacu is the Founder & CEO of Rêve Solutions Consulting and the creator of the CCIM™ framework. Over fifteen years in clinical trial supply chain across European and African corridors — including senior roles in global pharma — shape how Rêve approaches sponsor decisions.
Rigorously. Operationally. With primary-source corridor intelligence rather than secondary research.
He also chairs the RÊVE Diversity & Trials Taskforce — a six-country expert group producing a Strategic Framework & Operational Playbook on Diversity & Inclusion in Clinical Trials, publishing November 2026.
Révérien speaks regularly at the leading clinical trial supply forums in Europe and globally — including CTS Forums, GCSG, and World BI — introducing the CCIM™ framework to sponsor, CRO, and 3PL audiences.
We partner with sponsors at the decision layer — providing the regulatory intelligence, corridor expertise, governance design, and strategic ROI analysis that turns Africa from a question mark into a confident strategic commitment.
You’ll have a reply within one business day.